Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 2 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.


Player Avatar KickBackAt40 (85.02) Submitted: 2/4/2013 11:25:56 AM : Underperform Start Price: $35.22 INFI Score: -23.73

Started a synthetic short @ $35.28 by selling Aug 50 calls and buying Aug 50 puts.

Featured Broker Partners